帕金森病的概述:一个叙事审查
Hiba Shamweel1, Shamweel Ahmad2
1Research Scholar, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia.
Informatics for health & social care
|February 16, 2026
概括
帕金森病 (PD) 管理正在不断发展,随着物理治疗和新兴技术,如AI增强诊断和治疗. 本综述探讨了PD,其风险因素,以及改善患者结果的创新康复策略.
科学领域:
- 神经学 神经学
- 康复科学 康复科学 康复科学
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特点是运动和非运动症状.
- 姿势不稳定 (PI) 是PD的一个关键症状,显著影响患者的残疾和生活质量.
研究的目的:
- 审查目前对PD的理解,包括病理生理学,诊断,风险因素和管理策略.
- 突出PD护理的进步,重点关注物理治疗,数字健康和人工智能 (AI).
主要方法:
- 对帕金森病现有研究的文献综述.
- 分析诊断标准,风险因素和治疗方法 (药物和非药物).
主要成果:
- 患PD的诊断依赖于临床评估,运动波动和对多巴胺疗法的反应.
- 物理治疗是PD症状管理的基石.
- 数字健康技术和人工智能在改善PD诊断和患者结果方面表现有前途.
结论:
- 有效的PD管理需要一个多方面的方法,结合药理和非药理干预措施.
- 新兴技术正在改变PD护理,为诊断,治疗和康复提供新的途径.
- 对创新工具和人工智能的进一步研究对于提高PD患者的治疗结果至关重要.
相关概念视频
Parkinson's Disease: Overview
2.1K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.1K
Parkinson's Disease: Treatment
1.2K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K
Alzheimer's Disease: Overview
1.8K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.8K
Lysosomal Hydrolases
4.6K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.6K
Psychosis and Antipsychotic Drugs: Overview
943
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
943


